Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.725 USD | +4.63% | +3.77% | +591.81% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+591.81% | 195M | |
+7.49% | 111B | |
+11.39% | 106B | |
-12.52% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+37.12% | 12.54B | |
-24.15% | 8.09B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Cuts Elevation Oncology's Price Target to $21 From $27, Citing 'Financing Environment;' Outperform Rating Kept